These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32283140)

  • 1. Re: Profile of specific antibodies to SARS-CoV-2: The first report.
    Zeng Z; Chen L; Pan Y; Deng Q; Ye G; Li Y; Wang X
    J Infect; 2020 Jul; 81(1):e80-e81. PubMed ID: 32283140
    [No Abstract]   [Full Text] [Related]  

  • 2. Profile of specific antibodies to SARS-CoV-2: The first report.
    Xiao AT; Gao C; Zhang S
    J Infect; 2020 Jul; 81(1):147-178. PubMed ID: 32209385
    [No Abstract]   [Full Text] [Related]  

  • 3. Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19).
    Al-Tawfiq JA
    Travel Med Infect Dis; 2020; 35():101608. PubMed ID: 32114075
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Testing recommendation for COVID-19 (SARS-CoV-2) in patients planned for surgery - continuing the service and 'suppressing' the pandemic.
    O' Connell K; Fitzpatrick F; Richmond A; Foley M; Martin F
    Br J Oral Maxillofac Surg; 2020 Jul; 58(6):733. PubMed ID: 32425293
    [No Abstract]   [Full Text] [Related]  

  • 5. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
    Bölke E; Matuschek C; Fischer JC
    N Engl J Med; 2020 Oct; 383(17):1694-1695. PubMed ID: 32966710
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of SARS-CoV-2 antibodies in COVID-19: Healing in most, harm at times.
    French MA; Moodley Y
    Respirology; 2020 Jul; 25(7):680-682. PubMed ID: 32436320
    [No Abstract]   [Full Text] [Related]  

  • 7. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19. Reply.
    Yang OO; Ibarrondo FJ
    N Engl J Med; 2020 Oct; 383(17):1697-1698. PubMed ID: 32966713
    [No Abstract]   [Full Text] [Related]  

  • 8. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
    Kutsuna S; Asai Y; Matsunaga A
    N Engl J Med; 2020 Oct; 383(17):1695-1696. PubMed ID: 32966712
    [No Abstract]   [Full Text] [Related]  

  • 9. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
    Terpos E; Mentis A; Dimopoulos MA
    N Engl J Med; 2020 Oct; 383(17):1695. PubMed ID: 32966711
    [No Abstract]   [Full Text] [Related]  

  • 10. From SARS-CoV to SARS-CoV-2: The response and challenge of forensic infectious disease autopsy.
    Wang HJ
    Fa Yi Xue Za Zhi; 2020 Feb; 36(1):1-3. PubMed ID: 32198983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Going back in time for an antibody to fight COVID-19.
    Whittaker GR; Daniel S
    Nature; 2020 Jul; 583(7815):203-204. PubMed ID: 32623442
    [No Abstract]   [Full Text] [Related]  

  • 12. Finding Camel-ot: A Holy Grail against pandemic SARS-CoV-2?
    Soong D; Leeman R; Pillai A
    Sci Immunol; 2020 Jul; 5(49):. PubMed ID: 32620562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The index case of SARS-CoV-2 in Scotland.
    Hill KJ; Russell CD; Clifford S; Templeton K; Mackintosh CL; Koch O; Sutherland RK
    J Infect; 2020 Jul; 81(1):147-178. PubMed ID: 32205138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cluster of pneumonia associated with the SARS-Cov-2 outside of Wuhan related to a house-warming banquet.
    Liu L; Quan J; Lv J; Long S; Hu W; Zhuge H; Zhou Z; Zhao D
    J Infect; 2020 Jul; 81(1):147-178. PubMed ID: 32283138
    [No Abstract]   [Full Text] [Related]  

  • 15. Challenges and issues of SARS-CoV-2 pool testing.
    Lee J; Kim SY; Sung H; Lee SW; Lee H; Roh KH; Yoo CK; Hong KH
    Lancet Infect Dis; 2020 Nov; 20(11):1232-1233. PubMed ID: 32679080
    [No Abstract]   [Full Text] [Related]  

  • 16. Challenges and issues of SARS-CoV-2 pool testing.
    Mishra B; Behera B; Mohanty M; Ravindra A; Ranjan J
    Lancet Infect Dis; 2020 Nov; 20(11):1233. PubMed ID: 32679083
    [No Abstract]   [Full Text] [Related]  

  • 17. Challenges and issues of SARS-CoV-2 pool testing.
    Eberhardt JN; Breuckmann NP; Eberhardt CS
    Lancet Infect Dis; 2020 Nov; 20(11):1233-1234. PubMed ID: 32679088
    [No Abstract]   [Full Text] [Related]  

  • 18. SARS-CoV-2 and enhancing antibodies.
    Denner J
    J Clin Virol; 2020 Jul; 128():104424. PubMed ID: 32438257
    [No Abstract]   [Full Text] [Related]  

  • 19. Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients.
    Lee YL; Liao CH; Liu PY; Cheng CY; Chung MY; Liu CE; Chang SY; Hsueh PR
    J Infect; 2020 Aug; 81(2):e55-e58. PubMed ID: 32335168
    [No Abstract]   [Full Text] [Related]  

  • 20. Duration of SARS-CoV-2 viral RNA in asymptomatic carriers.
    Yan X; Han X; Fan Y; Fang Z; Long D; Zhu Y
    Crit Care; 2020 May; 24(1):245. PubMed ID: 32448332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.